 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1055
Advances in Coronary Angioplasty: Drug Eluting Stents
|
Description: |
The development of drug-eluting stents has emerged since the use of stenting became particularly prevalent, especially in the US. Stents are currently used in approximately 70%-90% of cardiovascular interventional procedures and have been shown to reduce the need for repeat percutaneous transluminal coronary angioplasty (Ptca) due to restenosis. There are, however, issues of in-stent thrombosis and in-stent restenosis that need to be addressed when analyzing the results of clinical trial data. Over the next few years, additional long-term studies will aim to provide details of the long-term outcome for drug-eluting stents. In light of recent advances in this field of research, this brief sets out to: *describe the stenting procedure and outline the overall use of stents in coronary interventional procedures *outline recent advances in procedures, such as brachytherapy and sonotherapy, and establish the main advantages and disadvantages of each type of intervention *analyze clinical trial data and company strategies for key drug-eluting stent programs, including in-depth review of sirolimus-eluting, paclitaxel-eluting and actinomycin D-eluting stent trials *compare drug-eluting stent developments against established interventions in order to determine the potential success and patient population for drug-eluting stents *provide a forecasted market size for the drug-eluting stent market to 2005, along with an identification of the key factors influencing the market during this period * analyze the potential impact of drug-eluting stents on pharmaceutical companies, in terms of the affect on the use of anti-thrombotic and anti restenotic agents. |
|
Contents: |
Datamonitor Healthcare
CONTACT DETAILS
TABLE OF CONTENTS
EXECUTIVE SUMMARY
Introduction
The history of angioplasty
Current use of stents in interventional therapy
Definition of stenting
In-stent restenosis
Increased intervention costs
Epidemiology overview
Percutaneous transluminal coronary angioplasty (PTCA)
Recent advances in stent therapy
Brachytherapy
Sonotherapy
Coated stents
Radioactive stents
Pipeline for drug-eluting stents
Sirolimus-eluting stent
RAVEL: zero restenosis
Cypher: Is it really too good to be true?
Will drug-eluting stents prove too costly?
Potential strategic alliances for Cordis
Market implications of drug-eluting stents
Paclitaxel-eluting stents
SCORE trial terminated
Increasing presence in the medical device market
Initial results from the paclitaxel-eluting stent trial
Strategic alliances to maximize potential revenue
Actinomycin D-eluting stent
Comparative analysis
Competition between drug-eluting stents
Market forecasts for drug-eluting stents
Potential impact on antithrombotic drug therapy?
Appendix
Bibliography
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/1055
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 08/09/2008 00:42:04 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Advances in Coronary Angioplasty: Drug Eluting Stents
|
|
Web Address: |
http://www.researchandmarkets.com/reports/1055
|
|
Office Code: |
|
OCHHIIQSTVT
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Hard Copy
|
|
€1,669.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic
|
|
€1,605.00
|
|
Electronic
- Site License
|
|
€1,605.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
 |
Page 2 of 2 Printed 08/09/2008 00:42:04
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
|
 |
 |
|
|